نتائج البحث - Ram Kalpatthi

  • يعرض 1 - 7 نتائج من 7
تنقيح النتائج
  1. 1
    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP)

    Long‐term use of the thrombopoietin‐mimetic romiplostim in children with severe chronic immune thrombocytopenia (ITP) حسب James B. Bussel, Loan Hsieh, George R. Buchanan, Kimo C. Stine, Ram Kalpatthi, David J. Gnarra, Richard Ho, Kun Nie, Melissa Eisen

    منشور في 2014
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Developmental Function in Toddlers With Sickle Cell Anemia

    Developmental Function in Toddlers With Sickle Cell Anemia حسب F. Daniel Armstrong, T. David Elkin, R. Clark Brown, Penny Glass, Sohail Rana, James F. Casella, Ram Kalpatthi, Steven G. Pavlakis, Zhibao Mi, Winfred C. Wang

    منشور في 2013
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia

    Immunologic Effects of Hydroxyurea in Sickle Cell Anemia حسب Howard M. Lederman, Margaret A. Connolly, Ram Kalpatthi, Russell E. Ware, Winfred C. Wang, Lori Luchtman‐Jones, Myron A. Waclawiw, Jonathan C. Goldsmith, Andrea J. Swift, James F. Casella

    منشور في 2014
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Impact of hydroxyurea on clinical events in the BABY HUG trial

    Impact of hydroxyurea on clinical events in the BABY HUG trial حسب Courtney D. Thornburg, Beatrice Files, Zhaoyu Luo, Scott T. Miller, Ram Kalpatthi, Rathi V. Iyer, Phillip Seaman, Jeffrey D. Lebensburger, Ofelia Álvarez, Bruce Thompson, Russell E. Ware, Winfred C. Wang

    منشور في 2012
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years

    Safety and efficacy of voxelotor in pediatric patients with sickle cell disease aged 4 to 11 years حسب Jeremie H. Estepp, Ram Kalpatthi, Gerald M. Woods, Sara Trompeter, Robert I. Liem, Kacie Sims, Adlette Inati, Baba Inusa, Andrew Campbell, Connie M. Piccone, Miguel R. Abboud, Kim Smith‐Whitley, Sandra Dixon, Margaret Tonda, Carla Washington, Noelle M. Griffin, R. Clark Brown

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design

    The pediatric hydroxyurea phase III clinical trial (BABY HUG): Challenges of study design حسب Bruce Thompson, Scott T. Miller, Zora R. Rogers, Renée C. Rees, Russell E. Ware, Myron A. Waclawiw, Rathi V. Iyer, James F. Casella, Lori Luchtman‐Jones, Sohail Rana, Courtney D. Thornburg, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lori Luck, Winfred C. Wang

    منشور في 2009
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)

    Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG) حسب Winfred C. Wang, Russell E. Ware, Scott T. Miller, Rathi V. Iyer, James F. Casella, Caterina P. Minniti, Sohail Rana, Courtney D. Thornburg, Zora R. Rogers, Ram Kalpatthi, Julio C. Barredo, R. Clark Brown, Sharada A. Sarnaik, Thomas H. Howard, Lynn Wynn, Abdullah Kutlar, F. Daniel Armstrong, Beatrice Files, Jonathan C. Goldsmith, Myron A. Waclawiw, Xiangke Huang, Bruce Thompson

    منشور في 2011
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: